Canada markets closed

NeuroSense Therapeutics Ltd. (NRSN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.1800+0.0300 (+2.61%)
At close: 04:00PM EDT
1.1600 -0.02 (-1.69%)
After hours: 06:09PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 20.45M
Enterprise Value 17.96M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.15
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.16

Trading Information

Stock Price History

Beta (5Y Monthly) 1.71
52-Week Change 3-30.99%
S&P500 52-Week Change 326.27%
52 Week High 32.3300
52 Week Low 30.4000
50-Day Moving Average 31.5940
200-Day Moving Average 31.0576

Share Statistics

Avg Vol (3 month) 3291.88k
Avg Vol (10 day) 3107.74k
Shares Outstanding 517.33M
Implied Shares Outstanding 617.33M
Float 811.15M
% Held by Insiders 128.56%
% Held by Institutions 10.77%
Shares Short (Apr 30, 2024) 418.15k
Short Ratio (Apr 30, 2024) 40.1
Short % of Float (Apr 30, 2024) 40.13%
Short % of Shares Outstanding (Apr 30, 2024) 40.10%
Shares Short (prior month Mar 28, 2024) 463.72k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-152.74%
Return on Equity (ttm)-602.40%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -13.28M
Net Income Avi to Common (ttm)-11.28M
Diluted EPS (ttm)-0.8300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.64M
Total Cash Per Share (mrq)0.17
Total Debt (mrq)142k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.84
Book Value Per Share (mrq)-0.12

Cash Flow Statement

Operating Cash Flow (ttm)-8.45M
Levered Free Cash Flow (ttm)-3.71M